Source: International Congress 2018 – New developments in the treatment of asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Kwon (Brentford, Middlesex, United Kingdom), K. Gemzoe (Stockley Park, Uxbridge, Middlesex, United Kingdom), S. Worsley (Stockley Park, Uxbridge, Middlesex, United Kingdom), N. Gunsoy (Stockley Park, Uxbridge, Middlesex, United Kingdom), S. Joksaite (Stockley Park, Uxbridge, Middlesex, United Kingdom), M. Van Dyke (Upper Providence, PA, United States of America), C. Bettinson (Stockley Park, Uxbridge, Middlesex, United Kingdom), F. Albers (Research Triangle Park, NC, United States of America). Characteristics of patients receiving mepolizumab in real-world practice –REALITI-A study. 1036

Member's Comments

No comment yet.

Related content which might interest you: Physician assessment of asthma control in patients receiving omalizumab in a real-world setting Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Biomarker measurement in asthma patients receiving biologic therapy: a real-world retrospective study Source: International Congress 2018 – Eosinophils in airway disease Year: 2018 MARTE: an observational study on clinical and sociodemographic characteristics of asthmatic patients receiving maintenance and rescue treatment in Spain Source: International Congress 2018 – Asthma: clinical screening tools Year: 2018 Phenotypes related with clinical improvement of omalizumab-treated patients in routine clinical practice. FENOMA Study Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Analysis of two-year treatment with omalizumab patients with severe asthma in real clinical practice Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Anti-inflammatory asthma therapy adherence in paediatric patients: The PACMAN cohort study Source: Annual Congress 2010 - Management of airway disease Year: 2010 Effect of excluding ICU-admission on clinical outcomes in a randomized control trial studying the effect of corticosteroids in patients hospitalized with CAP Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Time on therapy and concomitant medication use of mepolizumab in Canada: a retrospective cohort study Source: ERJ Open Res, 7 (1) 00778-2020; 10.1183/23120541.00778-2020 Year: 2021 The ARIETTA study: baseline demographics in a real-world setting in patients with severe asthma Source: International Congress 2017 – Bronchial asthma management Year: 2017 Treatment eligibility of mepolizumab-treated severe asthma patients in clinical practice Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Real-life effectiveness of omalizumab in difficult-to-treat versus severe asthma: a national cohort study in Belgium Source: ERJ Open Res, 5 (4) 00253-2018; 10.1183/23120541.00253-2018 Year: 2019 Efficacy and safety of pirfenidone in patients with IPF. A single center real-life experience. Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside Year: 2017 Budesonide/formoterol maintenance and reliever therapy for asthma compared to conventional best practice: a randomised real-life study Source: Eur Respir J 2006; 28: Suppl. 50, 613s Year: 2006 Efficacy of the using budesonide/formoterol in patients with bronchial asthma (BA): the study of routine clinical practice Source: Eur Respir J 2006; 28: Suppl. 50, 499s Year: 2006 Evaluation of roflumilast in COPD patients in a real-world European setting: results from the PROFILE EU study Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 Can Internet-based management improve asthma control? A long term randomised clinical study of 300 asthmatics Source: Eur Respir J 2005; 26: Suppl. 49, 44s Year: 2005 Efficacy and safety of once-daily low-dose indacaterol/mometasone via Breezhaler® in symptomatic adult and adolescent patients with inadequately controlled asthma: Phase III randomised QUARTZ study findings Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Asthma Year: 2019 Assessment and therapy for COPD patients in real-life primary care Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Use of inhaler devices in elderly patients with respiratory disease: real-world observational study Source: International Congress 2019 – Inhalers: adherence and preference Year: 2019 Italian real-life experience of omalizumab Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009